Clearside Biomedical Inc Cash Flow Reinvestment Rate
Latest as of December 2023:
0.48x
Clearside Biomedical Inc cash flow reinvestment rate. Clearside Biomedical Inc (CLSD) has a Cash Flow Reinvestment Rate of 0.48x as of December 2023, reinvesting $240.00K (capex $120.00K plus investments $-120.00K) from operating cash flow of $495.00K. Explore Clearside Biomedical Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.48x
(Capex + Investments) / Operating CF
Total Reinvested
$240.00K
Capex + Investments
Operating Cash Flow
$495.00K
USD
Capital Expenditures
$120.00K
USD
Clearside Biomedical Inc Cash Flow Reinvestment Rate by Year (None–None)
Clearside Biomedical Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Clearside Biomedical Inc. For the full cash flow conversion analysis, see Clearside Biomedical Inc cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow